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Background: The Ontario Breast Screening Program (OBSP) is a population-based breast screening programme, not
requiring physician referral. OBSP invites women by mail to book their next screens. However, women who do not
participate in the OBSP, may be referred by physicians to non-OBSP mammography facilities, which do not remind
women to book their next screen.
Methods: We identified women without breast cancer prior to June 30, 2011, having bilateral mammography (M)
during a baseline period at age 50 – 69 at OBSP or non-OBSP facilities, and during a re-exposure period, at the
same facility type. We used a case-control design to study the association of facility type and having M during an
outcome period. Cases were women failing to receive the outcome M. Controls were matched by age, census tract,
and socioeconomic status. Exposure was baseline facility type. Covariates were comorbidity, residential mobility, and
primary care physician (PCP) characteristics. Conditional logistic regression analysis was performed.
Results: Cases were less likely to have been screened at OBSP facilities. Failure to receive the outcome M was
associated with having moved after re-exposure M (OR = 1.61, 95% confidence interval (CI) 1.52, 1.71), having a male
PCP (OR = 1.05, 95% CI 1.02, 1.05), or a higher Charlson score (OR = 1.06 per unit increase, 95% CI 1.03, 1.09). Having
re-exposure M at an OBSP facility (OR = 0.18, 95% CI 0.18, 0.19)., having a Canadian trained PCP (OR = 0.83, 95%
CI 0.8, 0.87), and having a PCP one year after the re-exposure M (OR = 0.81, 95% CI 0.68, 0.97) were protective
against failure to receive the outcome M.
Conclusions: The OBSP, not requiring physician referral, and inviting women by mail to book their next screen, is
associated with a lower probability of failure to reattend for subsequent screening than screening by PCP referral to
non-OBSP facilities.
Keywords: Breast cancer screening, Case control study, Reminder letters, Canada, Ontario Breast Screening ProgramBackground
Several randomized trials and meta analyses have shown
that periodic screening with mammography reduces
breast cancer mortality among women by around 14 to
35 percent with regular screening [1-3], depending on age
and the specific trial [4,5]. Current Canadian guidelines
recommend screening mammography every 2-3 years for
average risk women aged 50-69 [6].* Correspondence: lawrence.paszat@ices.on.ca
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unless otherwise stated.Breast screening in Ontario
The Ontario Breast Screening Program (OBSP) is a population-
based breast screening program for women 50 – 69 years
of age previously unaffected by breast cancer, and does
not require women to be referred by a physician. The
OBSP invites women by mail to book their next screen,
when it comes due. The OBSP has a website with infor-
mation for physicians and for screen-eligible women. It
does not conduct risk assessments or counsel women at
entry or at reattendance. It sends screening results to the
woman, and to a primary care physician if she has identi-
fied a physician to the programme.ntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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do not attend the OBSP for whatever reason, may be re-
ferred by physicians to non-OBSP mammography facilities
for screening mammography (M). These facilities do not
accept self-referral by age-eligible women (women may
not book their own appointments) and do not remind the
woman or the physcian when the next screen is due. For
some women a non-OBSP facility may be more conveni-
ent. These facilities send the results of each screen to the
referring physician, but not to the woman.
Previous work from the OBSP has identified several
factors that affect reattendance for the next screen [7],
but this work did not compare OBSP reattendance with
reattendance at other facilities. The effect of patient re-
minders on mammography attendance has previously
been studied in other jurisdictions [8-10]. In a random-
ized trial, Mayer et al. found that the group receiving a
reminder letter from the mammography facility had a
46.6% return rate and the group receiving no letter had
a 28.3% return rate [8].
Primary care in Ontario
In Ontario, primary care is provided chiefly by non-
specialist physicians, who may or may not have had 2 or
3 years post graduate training in family medicine.
Universal single governmental health insurance in
Ontario
All women who are permanent residents or refugees
in Ontario are ensured by the government for bilateral
mammography at both types of mammography facility.
The Ministry of Health provides lump sum financial in-
centive payments to physicians who report various levels
of participation among their eligible patients. These incen-
tives apply to both OBSP and non-OBSP screened women.
However, we have recently shown that these incentives do
not increase attendance for screening mammography in
Ontario [11].
Ethics
The Sunnybrook Health Sciences Center Research Ethics
Board approved this study (project number PO940 010).
Written consent was not obtained as the study was en-
tirely registry-based and did not involve biological samples




The Registered Persons Database (RPDB) is a roster of
beneficiaries of the Ontario Health Insurance Plan (OHIP),
for which all permanent residents and refugees are eligible
free of charge. The RPDB contains the postal code of
each beneficiary, allowing the linkage of each beneficiaryto Statistics Canada data on residence and census-level
variables, such as socio-economic status. From the OHIP
physician claims billing database we obtained records of
mammography, breast ultrasound, breast MRI, breast bi-
opsies and breast surgery from 2005 - 2011. All records
are identified by the service code, date of service, physician
identifier and an encryption of the unique numeric health
insurance number which allows deterministic linkage
of each beneficiary to all provincial databases. The physi-
cians billing for services to each beneficiary are analyzed,
in order to determine if each beneficiary has, or does not
have, a usual primary care physician. From the OBSP
database we obtained all dates of breast screening between
2005 and 2011. From the Ontario Cancer Registry we
identified all dates of diagnosis of breast cancer prior
to December 31, 2011. Information about physician
age, sex, country of education, and years in practice
was obtained from the Corporate Providers’ Database
(CPDB).Study population
We identified women without breast cancer or mastec-
tomy prior to June 30, 2011, having bilateral mammog-
raphy (M) during a baseline period at ages 50 – 69 at
OBSP or non-OBSP facilities, and during a re-exposure
period at the same type of mammography as at baseline.
Women were excluded if baseline M or re-exposure M
were followed by other diagnostic imaging of the breast,
breast biopsy or breast surgery, or, if no usual primary
care physician could be identified as of the date of re-
exposure M.
Women who received the outcome M within the ex-
pected interval of 11 months to 30 months following re-
exposure M comprised the controls, while those who
failed to receive the outcome M comprised the cases.
Multiple controls were matched to cases by age, census
tract, and urban median household income quintile/rural
residence at January 1, 2008.Exposure to breast screening and definition of baseline,
re-exposure and outcome periods
The baseline period was December 1, 2005 to June 30,
2007. The re-exposure period was January 1, 2008 to
June 30, 2008, and the interval between baseline M and
re-exposure M was defined as 11 to 30 months. This pro-
vides a population of observations for whom the pattern
of periodic screening is established in the baseline and re-
exposure periods. If the baseline M and re-exposure M
had been provided by the OBSP, an invitation letter
would have been sent to each woman, approximately
24 months later. The outcome period was defined as 11 to
30 months after the re-exposure M, and ended no later
than December 31, 2010.
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We used a case-control design to study the association
between the type of mammography facility, and the failure
to receive the outcome M. Cases were women who failed
to receive the outcome M. Controls did receive the out-
come M and were matched to controls by age, census
tract, and socioeconomic status. Exposure was the type of
mammography facility for each women. Covariates were
comorbidity, residential mobility, and primary care phys-
ician (PCP) characteristics.
Definition of adjusting variables
Cumulative (5 year) Charlson score as of January 1, 2008
Using the Deyo modification of the Charlson score for
administrative data, we calculated the Charlson score ac-
cumulated during the 5 years prior to the re-exposure
date for all women.
Having a primary care physician (yes/no) one year after
re-exposure M.
Women had an identifiable primary care physician on
the date of the re-exposure M, as an eligibility criterion,
ascertained from OHIP records. We ascertained whether
or not each woman had a usual primary care physician
(PCP) twelve months after the re-exposure M. Any
woman might not have a usual PCP at that time, because
of personal preference, retirement or relocation of the
PCP, or the woman having moved to a different commu-
nity. OHIP does not assign any beneficiary to a particular
physician, it is the responsibility of the beneficiary to find
one who will accept her as a patient.
Gender of primary care physician
For each woman, the gender of her primary care phys-
ician was extracted from the CPDB.
Location of medical education of primary care physician
The CPDB contains name of the medical school attended
by each physician, and the name of the country in which
the medical school was located. We categorized the phys-
ician of each woman as Canadian-trained, Anglosphere –
trained (US, UK, Ireland, Australia, New Zealand, South
Africa), or Other-trained.
Years in practice of primary care physician
The number of years spent in practice were extracted
for each PCP from the CPDB.
Postal code change one year after 2008 mammography
We identified for each woman whether she had moved
by 12 months following the index date by searching for
a change in postal code. This would identify a potential
barrier to her receiving an invitation letter for reatten-
dance at breast screening thereafter due to delays inrecording address changes, and might signify that the
woman would no longer be able to attend her usual PCP.
Statistical analyses
Conditional logistic regression was conducted to estimate
the odds ratio for failure to receive the outcome M, treat-
ing the type of mammography facility of the baseline and
re-exposure M as the exposure variable, adjusting for the
variables described above.
Results
The study population comprised 105,665 women, whose
description is tabulated in Table 1. There were more
women in the upper income quintiles compared to lower.
On the index date, 93.6% of women had a Charlson co-
morbidity score of ‘zero’. 60.6% of the women had a male
primary care physician and 77% of the women had a
Canadian-educated primary care physician. We were able
to identify a primary care physician for 99.2% of the study
population one year after the date of the re-exposure M.
At that time, 5.9% of women had moved to a different ad-
dress (evidenced by a change in postal code).
Women in the lowest urban income quintile were less
likely to reattend for screening after the index date (71.1%)
compared to the highest income quintile. (75.6%). Women
with a Charlson comorbidity score = 3, on the index date,
were more likely to fail to receive the outcome M (only
70.3% reattended) compared to those with a score of ‘zero’
(74.6% reattended).
Among the study population, 59.6% had received their
baseline and re-exposure M at an OBSP facility, and 40.4%
elsewhere. Among women with a Canadian-educated
PCP, 24.8% failed to receive the outcome M, compared to
26.1% of those with a PCP educated elsewhere in the
Anglosphere, and 29.3% if the PCP was educated else-
where. 65.6% of women who had changed addresses by
one year after the index date reattended compared to
75.0% of those who had not.
Among those women screened at an OBSP facility,
14.1% failed to receive the outcome M between 11 months
and 30 months after the re-exposure M, not later than
December 31, 2010, compared to 43.3% of the other
women. Failing to receive the outcome M was independ-
ently associated with a higher Charlson comorbidity score
(OR = 1.06 per one unit increase in score, 95% confidence
interval 1.03-1.09), having a male physician (OR = 1.05, 95%
confidence interval 1.02-1.05), and having changed postal
codes within one year after the re-exposure M (OR= 1.63,
95% confidence interval 1.53-1.73). Having the previous
mammogram at an OBSP facility (OR = 0.18, 95% confi-
dence interval 0.18-0.19), and having a Canadian trained
(OR = 0.83, 95% confidence interval 0.80-0.87) or
Anglosphere- trained physician (OR = 0.91, 95% confi-
dence interval 0.84-0. 98) rather than a foreign-trained
Table 1 Characteristics of the study population
Factor All women (n = 105,665)
Entire sample (% of total) Cases (% of total) Controls (% of total)
Socioeconomic status quintiles
First urban quintile (lowest) 12,499 (11.8%) 3,612 (13.4%) 8,887 (11.3%)
Second urban quintile 15,686 (14.8%) 4,364 (16.2%) 11,322 (14.4%)
Third urban quintile 16,523 (15.6%) 4,432 (16.4%) 12,091 (15.4%)
Fourth urban quintile 19,040 (18.0%) 5,011 (18.6%) 14,029 (17.8%)
Fifth urban quintile (highest) 23,555 (22.3%) 5,752 (21.3%) 17,803 (22.7%)
Rural 18,259 (17.3%) 3,794 (14.1%) 14,465 (18.4%)
Missing 103 (0.1%) 35 68
Age at initial scan
50-54 28, 090 (26.6%) 7,710 (28.6%) 20,380 (25.9%)
55-59 32,413 (30.7%) 8,001 (29.6%) 24,412 (31.1%)
60-64 26,663 (25.2%) 6,501 (24.1%) 20,162 (25.7%)
65-69 18,499 (17.5%) 4,788 (17.7%) 13,711 (17.4%)
Cumulative Charlson score on index date
0 98,885 (93.6%) 25,135 (93.1%) 73,750 (93.8%)
1 3,762 (3.6%) 1,049 (3.9%) 2,713 (3.5%)
2 2,115 (2.0%) 548 (2.0%) 1,567 (2.0%)
≥3 903 (0.9%) 268 (1.0%) 635 (0.7%)
Women by gender of their PCP at index date
F 41,616 (39.4%) 10588 (39.2%) 31028 (39.5%)
M 64,049 (60.6%) 16412 (60.8%) 47637 (60.5%)
Women by country of education of physician on index date
Canadian 82,020 (77.6%) 20322 (75.3%) 61,698 (78.5%)
Anglosphere 7.639 (7.2%) 1995 (7.4%) 5644 (7.2%)
Other 16,006 (15.1%) 4683 (17.3%) 11323 (14.3%)
Women by years since graduation of physician at index date
<10 5,573 (5.3%) 1,352 (5.0%) 4,221 (5.4%)
10-19 21,621 (20.5%) 5525 (20.5%) 16,186 (20.6%)
20-29 37,053 (35.1%) 9,522 (35.3%) 27,531 (35.0%)
30-39 30,671 (29.0%) 7,758 (28.7%) 22,913 (29.2%)
> = 40 10,657 (10.1%) 2,843 (10.5%) 7,814 (9.8%)
Women who still have a PCP at year one after index date
Yes 104,801 (99.2%) 26801 (99.3%) 78000 (99.2%)
No 854 (0.8%) 199 (0.7%) 655 (0.8%)
Women whose Postal code has changed from index date to year one
Yes 6,264 (5.9%) 2152 (8.0%) 4112 (5.1%)
No 99,401 (94.1%) 24848 (92.0%) 74553 (94.9%)
Baseline and re-exposure mammography facility
OBSP 63,264 (59.9%) 8,964 (33.2%) 54,230 (69.0%)
Non-OBSP 42,401 (40.1%) 18,036 (66.8%) 24,365 (31.0%)
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outcome M (Table 2).
Discussion
Being screened at an OBSP facility is associated with a
significantly lower likelihood of failing to receive subse-
quent breast screening, compared to being screened by
PCP referral at non-OBSP facilities, after adjusting for
Charlson comorbidity score, PCP gender, location of PCP
training, residential mobility (using postal code change at
one year), and whether the woman continued to have a
usual PCP 12 months after the re-exposure M.
Others have reported that women with poorer self re-
ported health are less likely to adhere to cancer screen-
ing [12], and specifically breast screening [13].
There is limited knowledge about the association of a
woman’s residential mobility with her continuing adher-
ence to screening mammography. Mobley et al. analyzed
Medicare data on California women and showed that
recent address change decreases the likelihood of using
screening mammography services by 7% [14]. The current
work shows that postal code change within a year of
the index mammogram increases the likelihood of
failure to receive the next periodic screening mammog-
raphy. Residential mobility may result in failed delivery ofTable 2 Factors affecting the likelihood of not reattending
Factor *





Gender of woman’s physician
Male
Female




Years in practice of woman’s physician, (per year)
Has a primary care physician one year after re-exposure M
Yes
No
Postal code change 1 year after re-exposure M
Yes
No
*This is a full model. All variables defined, described, and analyzed univariately and
and none were significant.the reminder, increased stress [13], or lack of a usual PCP
to refer for screening.
Martin-Lopez et al. found that women who received a
screening mammogram were more likely to have recently
visited a PCP [15], and Esteva et al. found that participants
in a public breast screening program visited their PCPs
more frequently in the previous year than non partici-
pants [16]. Recommendations from PCPs increase breast
screening participation [16,17], and it is likely that women
who visit PCPs are exposed to more recommendations
than those who do not. Duijm et al. found that barriers to
receiving follow-up screening mammography were PCP-
related rather than patient related in 70% of cases (in a
study of women at risk for breast cancer due to a positive
family history) [18]. Most of these barriers resulted from a
failure of the PCP to recall that the patient was due for a
screening mammogram. A programme such as the OBSP
may avoid such barriers and may empower the patient by
informing her directly when a mammogram is due.
It has been well described that female PCPs are more
likely to encourage screening mammography and pap
smears than their male counterparts [19-23]. In the current
work we report a small association of the failure to receive
the next periodic screening mammogram with male PCPs.















bivariately are included in this full model. All 2 way interactions were tested
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care, and believing more strongly in the effectiveness of
mammography [23].
Women having a Canadian trained PCP (OR = 0.83,
95% confidence interval 0.80-0.87) or a PCP who trained
in the Anglosphere (OR = 0.91, 95% confidence interval
0.84-0.98) were less likely to fail to receive the outcome
M compared to those having a PCP trained elsewhere in
the world (reference, OR = 1.0). Thind et al. analyzed the
practice patterns of Ontario PCPs using self reported
surveys and found that Canadian trained PCPs were
more likely to provide appropriate screening and pre-
ventive care than international medical graduates [24].
Our findings corroborate this.
Sin and Leger conducted a systematic review of inter-
ventions designed to increase breast screening uptake,
and identified 28 studies among 25 citations [25]. None
of these studies specifically examined failure to receive the
next periodic screening mammogram. Simple interven-
tions such as reminders were found to be efficacious at
improving attendance, and more complicated and costly
interventions were not more efficacious. Our findings also
show that simple reminder letters are associated with a
large increase in the likelihood of reattendance.
We matched on age, income, and census tract as mea-
sured confounders, therefore estimates for those variables
are not obtainable. There may be confounding factors not
accounted for in the present analysis. Women who re-
ceived the baseline M and re-exposure M at OBSP facilities
may be more oriented towards screening and preventive
health services than those who received the baseline M
and re-exposure M at non-OHIP facilities upon referral by
PCPs. These results are consistent with the hypothesis that
reminder letters sent by the OBSP to women who are due
to receive the next periodic screening mammograms pre-
vent failure to receive the next screen, compared to the
absence of such a reminder among women who receive
screening on referral by the PCP to non-OBSP mammog-
raphy facilities.
Conclusion
Women in enrolled the Ontario Breast Screening Program
(OBSP), a population-based breast screening programme
sending reminder letters to women due for the next peri-
odic screening, are less likely to fail to receive the next
screening, compared to those who receive screening only
when and if the PCP refers them to non-OBSP facilities.
Women with higher comorbidity burden, those who
change addresses after the index scan, and those without
usual PCPs are more likely to fail to receive the next
screen. The OBSP removes some of the barriers to breast
screening and is effective at increasing mammography
reattendance. Physician-referral based screening might
achieve higher reattendance if routine invitations toreattend were to be adopted by the non-OBSP mammog-
raphy facilities.
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